Novel method of leukocytapheresis using a highly concentrated sodium citrate solution alternative to acid citrate dextrose solution A
Transfusion · 2025-07 · 65 (7) · 1223-1230
DOI: 10.1111/trf.18280 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, online erschienen am 19.05.2025. Verfasst von Masaya Abe und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Transfusion and Cell Therapy, Okayama University Hospital, Okayama, Japan. Hauptthemen laut MEDLINE: Leukapheresis, Sodium Citrate, Glucose. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Large‐volume leukocytapheresis is time consuming. The upper limit of the inlet flow rate is determined by the inlet: anticoagulant (AC) ratio and can be changed by combining the AC with heparin. Here, we devised a protocol to increase the AC ratio using a highly concentrated sodium citrate solution without heparin. Study Design and Methods We collected data from 40 consecutive apheresis procedures performed using the Spectra Optia system on 40 donors for allogeneic peripheral blood stem cells between June 2022 and June 2023. We used AC containing 2.2% sodium citrate (normal concentrated sodium citrate [NSC]) and 5.32% sodium citrate (highly concentrated sodium citrate [HSC]). The AC ratios were set to 12:1 and 24:1 for the NSC and HSC, respectively.
Results
The processed volume was not different; the maximum inlet flow rate increased, the total processing time was reduced, the AC solution used was reduced, and the product volume was reduced in the HSC group, compared to the NSC group. Although the CD34+ cell CE2 was reduced in the HSC group, no difference was observed in the number of collected CD34+ cells. The incidences of citrate‐related reactions were similar.
Discussion
We propose a novel leukocytapheresis method using HSC that shortens the procedure time and reduces the amount of AC solution used compared to the conventional method.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Transfusion and Cell Therapy, Okayama University Hospital, Okayama, Japan.
- Division of Clinical Laboratory, Okayama University Hospital, Okayama, Japan.
- Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
- Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan.
- Department of Pediatric Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
- Department of General Medicine, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan.
ORCID-Profile: Keiko Fujii, Wataru Kitamura, Nobuharu Fujii
Zitieren
APA
Abe, M., Fujii, K., Mitsuhashi, T., Kitamura, W., Ikeuchi, K., Fukumi, T., Washio, K., Otsuka, F., Maeda, Y., & Fujii, N. (2025). Novel method of leukocytapheresis using a highly concentrated sodium citrate solution alternative to acid citrate dextrose solution A. Transfusion, 65(7), 1223-1230. https://doi.org/10.1111/trf.18280
Vancouver
Abe M, Fujii K, Mitsuhashi T, Kitamura W, Ikeuchi K, Fukumi T, et al. Novel method of leukocytapheresis using a highly concentrated sodium citrate solution alternative to acid citrate dextrose solution A. Transfusion. 2025;65(7):1223-1230. doi:10.1111/trf.18280
BibTeX
@article{Abe2025,
author = {Abe, Masaya and Fujii, Keiko and Mitsuhashi, Toshiharu and Kitamura, Wataru and Ikeuchi, Kazuhiro and Fukumi, Takuya and Washio, Kana and Otsuka, Fumio and Maeda, Yoshinobu and Fujii, Nobuharu},
title = {Novel method of leukocytapheresis using a highly concentrated sodium citrate solution alternative to acid citrate dextrose solution A},
journal = {Transfusion},
year = {2025},
volume = {65},
number = {7},
pages = {1223--1230},
doi = {10.1111/trf.18280}
}
EUVIMED